Skip to main content
Toggle navigation
Login
Home
Back
Favorite
Like
Facebook
Tweet
Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - NALIRIFOX
Saturday, September 30, 2023
11:35 AM – 11:50 AM
ET
Presenter(s)
Milind M. Javle, MD
MD Anderson Cancer Center, The University of Texas